New arginine substituted derivative of poly(allylamine hydrochloride) for heparin reversal
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New arginine substituted derivative of poly(allylamine hydrochloride) for heparin reversal
Authors
Keywords
-
Journal
MedChemComm
Volume 5, Issue 4, Pages 489
Publisher
Royal Society of Chemistry (RSC)
Online
2014-01-10
DOI
10.1039/c3md00374d
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heparin sensing and binding – taking supramolecular chemistry towards clinical applications
- (2013) Stephen M. Bromfield et al. CHEMICAL SOCIETY REVIEWS
- Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
- (2012) Ph Gabriel Steg et al. EUROPEAN HEART JOURNAL
- Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis
- (2012) Bartlomiej Kalaska et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Polyallylamine-conjugated thermo-responsive polymers for the rapid removal of phenolic compounds from water
- (2012) Tohru Saitoh et al. REACTIVE & FUNCTIONAL POLYMERS
- Self-Assembling Ligands for Multivalent Nanoscale Heparin Binding
- (2011) Ana C. Rodrigo et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cationic Derivatives of Dextran and Hydroxypropylcellulose as Novel Potential Heparin Antagonists
- (2011) Kamil Kamiński et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of the substructure and properties of immobilized peptides on silicon surface
- (2011) Fahimeh Shamsi et al. MATERIALS CHEMISTRY AND PHYSICS
- A Biomimetic Chitosan Derivates: Preparation, Characterization and Transdermal Enhancement Studies of N-Arginine Chitosan
- (2011) Hui-Xia Lv et al. MOLECULES
- Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate
- (2010) Anna Luganini et al. ANTIVIRAL RESEARCH
- In Vivo Neutralization of Unfractionated Heparin and Low-Molecular-Weight Heparin by a Novel Salicylamide Derivative
- (2010) Jacqueline Kuziej et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Chitosan Derivatives as Novel Potential Heparin Reversal Agents
- (2010) Kamil Kamiński et al. JOURNAL OF MEDICINAL CHEMISTRY
- Host−Guest Chemistry of Dendrimer−Drug Complexes. 5. Insights into the Design of Formulations for Noninvasive Delivery of Heparin Revealed by Isothermal Titration Calorimetry and NMR Studies
- (2010) Xueyan Feng et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
- (2010) Karen L. Furie et al. STROKE
- Postoperative bypass bleeding: A bypass-associated dilutional (BAD) coagulopathy?
- (2009) Brian S. Bull et al. BLOOD CELLS MOLECULES AND DISEASES
- Heparin Antagonism by Polyvalent Display of Cationic Motifs on Virus-Like Particles
- (2009) Andrew K. Udit et al. CHEMBIOCHEM
- Update on heparin: what do we need to know?
- (2009) Daniel S. Weitz et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Peptide amphiphile nanostructure–heparin interactions and their relationship to bioactivity
- (2008) Kanya Rajangam et al. BIOMATERIALS
- Antibiotic delivery polyurethanes containing albumin and polyallylamine nanoparticles
- (2008) Fernanda Crisante et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Surfen, a small molecule antagonist of heparan sulfate
- (2008) M. Schuksz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heparin—Focus on Safety
- (2008) Julie Golembiewski Journal of PeriAnesthesia Nursing
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started